COMPANY

TAS Medical

Location: Windermere, FL · source · Oct 14, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $3.89M (Form D filed Apr 10, 2026). SEC Form D 0001437749-26-012054 (Apr 10, 2026)
Evidence (1 event)
- Apr 10, 2026 · SEC Form D 0001437749-26-012054
  Name of Issuer: TAS Medical, Inc.; CIK: 1739794; Address: Windermere, FL; Submission type: D; Filing date: 2026-04-10; Industry Group: Other Technology; Date of First Sale: 2026-03-27; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 6511056; Total Amount Sold: 3888800; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

Jun 3, 2026 FDA FDA 510(k) clearance: Tissue Approximation System — K261484, Jun 3, 2026. Applicant at approval: Tas Medical, Inc. source ↗

Jun 3, 2026 FDA 510(k) clearance: Tissue Approximation System — K261484, Jun 3, 2026. Applicant at approval: Tas Medical, Inc. source ↗

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-12